Keywords: Roche, RoActemra, UK, NICE, Juvenile arthrtis, sJIA

UK’s NICE calls for more data on Roche’s RoActemra for sJIA

Article | 11 August 2011

Print This

In a draft guidance published yesterday, UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has asked ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in